share_log

Enovis (NYSE:ENOV Shareholders Incur Further Losses as Stock Declines 8.3% This Week, Taking Three-year Losses to 30%

Enovis (NYSE:ENOV Shareholders Incur Further Losses as Stock Declines 8.3% This Week, Taking Three-year Losses to 30%

Enovis(纽约证券交易所代码:ENOV)股东蒙受进一步损失,本周股价下跌8.3%,使三年跌幅达到30%
Simply Wall St ·  05/06 10:35

For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. Unfortunately, that's been the case for longer term Enovis Corporation (NYSE:ENOV) shareholders, since the share price is down 60% in the last three years, falling well short of the market return of around 17%. Even worse, it's down 15% in about a month, which isn't fun at all. Importantly, this could be a market reaction to the recently released financial results. You can check out the latest numbers in our company report.

对于许多投资者来说,选股的要点是产生比整个市场更高的回报。但几乎可以肯定的是,有时候你会买入低于市场平均回报率的股票。不幸的是,Enovis Corporation(纽约证券交易所代码:ENOV)的长期股东就是这种情况,因为股价在过去三年中下跌了60%,远低于17%左右的市场回报率。更糟糕的是,它在大约一个月内下降了15%,这一点都不好玩。重要的是,这可能是市场对最近公布的财务业绩的反应。你可以在我们的公司报告中查看最新的数字。

After losing 8.3% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.

在上周下跌8.3%之后,值得调查该公司的基本面,以了解我们可以从过去的表现中推断出什么。

Enovis isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn't make profits, we'd generally hope to see good revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

Enovis目前没有盈利,因此大多数分析师会着眼于收入的增长,以了解基础业务的增长速度。当一家公司没有盈利时,我们通常希望看到良好的收入增长。那是因为如果收入增长可以忽略不计,而且从来没有盈利,就很难确信一家公司能否实现可持续发展。

In the last three years Enovis saw its revenue shrink by 9.3% per year. That is not a good result. The share price decline of 17% compound, over three years, is understandable given the company doesn't have profits to boast of, and revenue is moving in the wrong direction. Having said that, if growth is coming in the future, now may be the low ebb for the company. We'd be pretty wary of this one until it makes a profit, because we don't specialize in finding turnaround situations.

在过去的三年中,Enovis的收入每年减少9.3%。这不是一个好结果。鉴于该公司没有利润可吹嘘,而且收入正朝着错误的方向发展,股价在三年内复合下跌了17%,这是可以理解的。话虽如此,如果未来出现增长,那么现在可能是公司的低潮。在它盈利之前,我们会非常警惕,因为我们不擅长寻找转机情况。

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

下图显示了收入和收入随时间推移的跟踪情况(如果您点击图片,可以看到更多细节)。

earnings-and-revenue-growth
NYSE:ENOV Earnings and Revenue Growth May 6th 2024
纽约证券交易所:ENOV收益和收入增长 2024年5月6日

Enovis is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. So it makes a lot of sense to check out what analysts think Enovis will earn in the future (free analyst consensus estimates)

Enovis为投资者所熟知,许多聪明的分析师都试图预测未来的利润水平。因此,看看分析师认为Enovis将来的收入很有意义(免费的分析师共识估计)

What About The Total Shareholder Return (TSR)?

那么股东总回报(TSR)呢?

We've already covered Enovis' share price action, but we should also mention its total shareholder return (TSR). The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. We note that Enovis' TSR, at -30% is higher than its share price return of -60%. When you consider it hasn't been paying a dividend, this data suggests shareholders have benefitted from a spin-off, or had the opportunity to acquire attractively priced shares in a discounted capital raising.

我们已经报道了Enovis的股价走势,但我们还应该提及其股东总回报率(TSR)。股东总回报率试图捕捉股息(就好像它们被再投资一样)以及向股东提供的任何分拆或折扣资本筹集的价值。我们注意到,Enovis的股东总回报率为-30%,高于其-60%的股价回报率。当你考虑到它没有派发股息时,这些数据表明股东已经从分拆中受益,或者有机会通过折扣融资收购定价诱人的股票。

A Different Perspective

不同的视角

While the broader market gained around 26% in the last year, Enovis shareholders lost 9.9%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 2%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. You could get a better understanding of Enovis' growth by checking out this more detailed historical graph of earnings, revenue and cash flow.

去年整体市场上涨了约26%,而Enovis的股东却下跌了9.9%。即使是优质股票的股价有时也会下跌,但我们希望在过于感兴趣之前看到企业基本指标的改善。长期投资者不会那么沮丧,因为他们本可以在五年内每年赚2%。最近的抛售可能是一个机会,因此可能值得查看基本面数据以寻找长期增长趋势的迹象。通过查看这张更详细的收益、收入和现金流历史图表,你可以更好地了解Enovis的增长。

We will like Enovis better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我们看到一些重大的内幕收购,我们会更喜欢Enovis。在我们等待的同时,请查看这份免费清单,列出了最近有大量内幕收购的成长型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发